Abstract. Introduction. RBMOnline - Vol 7. No Reproductive BioMedicine Online; on web 8 July 2003
|
|
- Alyson Pauline Patterson
- 6 years ago
- Views:
Transcription
1 RBMOnline - Vol 7. No Reproductive BioMedicine Online; on web 8 July 2003 Techniques Total quality improvement in the IVF laboratory: choosing indicators of quality Jacob Mayer obtained his Bachelor s and Master s degrees in Biology at Wright University in the USA. He continued his studies at The Johns Hopkins University where he obtained his PhD in Reproductive Physiology in He held a post-doctoral fellowship there from 1981 to He is currently Associate Professor and Reproductive Laboratories Director at the Jones Institute for Reproductive Medicine in Norfolk, Virginia, which is part of the East Virginia Medical School. He has published widely, is a member of numerous local and national committees and boards and has frequently presented papers at meetings. His particular interest is in quality management in the IVF laboratory. Dr Jacob Mayer Jacob F Mayer 1,3,, Estella Lynn Jones 1, Donna Dowling-Lacey 1, Fariba Nehchiri 2, Suheil J Muasher 2, William E Gibbons 1, Sergio C Oehninger 1 1 Department of Obstetrics and Gynecology, Jones Institute for Reproductive Medicine Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA 2 Department of Obstetrics and Gynecology, Jones Institute for Reproductive Medicine, Northern Virginia/DC Center, 8501 Arlington Boulevard, Suite 500, Fairfax, VA 22031, USA 3 Correspondence: mayerjf@evms.edu Abstract The purpose of this paper is to describe a programme of total quality improvement (TQI) within the IVF laboratory and to provide specific examples of indicators that could be used in such a TQI programme. Although TQI is sometimes confused with quality control (QC) and quality assurance (QA), there are major differences between the three quality plans: (i) QC is an activity designed to ensure that a specific element within the laboratory is functioning correctly; (ii) QA is a comprehensive programme designed to looks at a laboratory as a whole and to identify problems or errors that exist in an attempt to improve the entire process; (iii) TQI is also a comprehensive monitoring process designed not only to detect and eliminate problems, but also to enhance a laboratory s performance by exploring innovation and developing flexibility and effectiveness in all processes. Indicators used in a TQI plan should be objective, relevant to the laboratory, and measure a broad range of specific events or aspects of treatment that reflect the quality of care. for each of the indicators should be based on how the specific protocols used in the laboratory impact the outcomes and the nature of the indicators on quality of care. Keywords: assessment, improvement, indicators, IVF, laboratory, quality Introduction There is a common misconception that an embryology (IVF) laboratory s only responsibility is to perform clinical lab procedures. In fact, proper laboratory function requires the clinical IVF laboratory to engage in a cycle of activities beyond the realm of clinical assisted reproduction technology (ART) procedures. Some of these types of activities include consultation with the physician and clinical staff about the patient s treatment plan, ensuring that appropriate procedures are ordered, and proper identification of the patient/patient s specimens. In addition, there are a number of important activities that are continuous throughout the period of laboratory operation. Among these non-procedural function are a series of activities that are often confused (Rothmann, 1995): (i) Quality control (QC): these are activities designed to assure that a specific element within the laboratory is correct. An example of a common QC activity is documentation of refrigerator temperature on a daily chart. These measurements are compared to a range of acceptable limits that had been previously defined. This assures that one element of laboratory function, e.g. reagent storage, is being properly conducted. It should be noted that a QC programme treats each element that it monitors as an independent unit and does not attempt to measure the activities of the IVF laboratory as whole. (ii) Quality assurance (QA): quality assurance is a comprehensive programme for monitoring and evaluating an entire process. For an IVF laboratory, some common components of a QA programme would include: QC activities, a comprehensive written procedure manual, continuing educational activities, a programme for employee evaluation, a safety programme for the protection of both laboratory staff and patients, and the use of an external proficiency programme. QA programmes are designed to identify 695
2 696 problems or errors that exist in the laboratory and correct these defects. In this way, a QA programme looks at a laboratory as a whole and attempts to improve the entire process. (iii) Total quality improvement (TQI) is also a comprehensive monitoring process. However, TQI tries objectively to evaluate the quality of the IVF laboratory services provided to patients, employees, students, physicians, the parent institute, and the community. TQI does not seek simply to correct problems, nor is it a way to proactively eliminate errors. TQI also looks at ways to enhance a laboratory s performance by exploring innovation and developing flexibility and effectiveness in all processes. The purpose of this paper is to describe TQI within the IVF laboratory, and to provide some examples of IVF laboratory activities that could be monitored and evaluated as part of a TQI programme. TQI in the IVF laboratory The Joint Commission on Accreditation of Health Care Organizations (JCAHO) describes 10 steps for the development of a TQI programme for a healthcare organization (JCAHO, 1991): (i) Assign responsibility for overseeing the TQI plan In most cases, it will be the Laboratory Director who assumes overall responsibility for the laboratories TQI programme. (ii) Determine the scope of care for your facility The plan should identify all of the activities performed by your laboratory. This includes, but is not limited to, types of procedures, types of staff involved with these procedures, and when and where these services are provided. More specific examples of the kinds of questions that can be asked in order to determine the scope of care for an ART laboratory are: Does the laboratory perform IVF? GIFT? ZIFT? Does the laboratory offer use of donor spermatozoa in your treatment protocols? Does the laboratory treat single women or only married couples? Does the laboratory provide treatment every day of the week? The TQI plan should use the responses to these and other questions to develop a description of exactly what is the nature and extent of laboratory function. (iii) Identify important aspects of care List those important aspects of care and service that need to be monitored. Some aspects of care chosen for an IVF laboratory might include specimen collection, embryo culture, embryo assessment, transfer, and maintaining sterility. (iv) Identify indicators For each aspect of care identified in step iii, a few indicators of quality need to be chosen in order to monitor the related quality of care. Greater detail on this phase of TQI will be discussed in the following section. (v) Establish thresholds The threshold sets the critical level of quality laboratory performance for each indicator. Greater detail on this phase of TQI will also be discussed in the following section. (vi) Collect and organize the data The plan should indicate what data are to be collected. It should also specify how and by whom, the data will be collected. Decisions will need to be made also as to the nature of the data. Is it collected prospectively or retrospectively? Also, the samples size and frequency of collection will need to be established. (vii) Evaluate data After the data are collected, they need to be evaluated. (viii) Take action to improve care When an opportunity for improvement is recognized, an action plan is created and implemented to generate the improvement in patient care. The action plan represents an informed judgment about what needs to be changed to improve performance. (ix) Assess the effectiveness of the action plan Data continue to be collected and analysed to evaluate whether or not the action plan has really resulted in an improvement in patient care. (x) Documentation and reporting The conclusions, recommendations, actions and follow-up are all developed into a report and presented to the appropriate individuals. In an IVF setting, it is best to present the report to a TQI committee made-up of representatives from the entire ART team, physicians, nurses, laboratory staff, and administration. This preceding section was a quick summary of the elements necessary for the creation of a TQI programme. The remaining portion of this manuscript will concentrate on giving further details and suggestions for implementing step iv (identify indicators) and step v (establish thresholds) of a TQI plan for an IVF laboratory. Identify indicators within the IVF laboratory The indicators that are selected should have a number of specific characteristics. Indicators should be selected that are relevant to the aspects of care that have been identified for the IVF laboratory (see step iii). These indicators should also be related to the laboratory processes and outcomes. They should measure specific events or aspects of treatment that reflect the quality of care. It is also best if indicators are objective, since they are more easily measured and quantified. Often, it is helpful if the entire IVF team is asked to help identify and establish these indicators. Non-laboratory staff
3 from within the IVF team have a different perspective of patient care, and may be able to identify important indicators that may not be as evident from a laboratory viewpoint. A number of indicators have traditionally been used for IVF laboratories. Normal fertilization rates, polyspermic rates, embryo cleavage rates, intracytoplasmic sperm injection (ICSI) degeneration rates, implantation rates, pregnancy rates and thaw survival rates have been used as potential indicators of overall laboratory quality (Wiemer et al., 2001). True TQI involves more than an aggregate review of these indicators. If these same indicators are also monitored from other points of view, they can yield greater detail on the laboratory s performance and can help to indicate the type of corrective action needed to improve the quality of care. For instance, these same indicators could be used to assess the performance of individual laboratory staff, individual pieces of equipment, and specific supplies used in the in-vitro process. Technically demanding procedures such as ICSI are usually assessed through intra-laboratory comparisons of individual performance. Normal fertilization (2PN) rates, degeneration rates, implantation rates and pregnancy rates are all commonly used to determine if an individuals is able to perform the ICSI procedure at a technically acceptable level. Monitoring of individual performance usually results in the development of an action plan involving staff training or continuing education activities. Likewise, individual pieces of equipment can also be the target of performance assessment. For example, individual incubator chambers may be compared using such indicators as fertilization rates, cleavage rates or pregnancy rates. Action plans derived from reviews of equipment performance often suggest changes in equipment maintenance and replacement activities. Specific supplies used in the in-vitro process can be assessed using some of these same indicators. Different lots of media could be examined for changes in fertilization rates, cleavage rates, average embryo grade, average embryo cell number, or pregnancy. Such information may suggest that making changes in storage or shipping of supplies or even making a change in a vendor could improve quality. In addition to the clinical indicators that are most often measured in laboratories, other areas related to laboratory performance should also be incorporated. Safety indicators may include accident reports, incidents reports, specimen identification issues and patient infection rates. Indicators concerned with communication could involve clerical error rates on reports, timely dissemination of reports and mislabelling of specimens. Patient satisfaction indicators can be an important part of the effort to improve overall quality. Table 1 shows a few examples of the indicators an IVF laboratory may wish to use in its TQI plan. Clearly, a great number of other potential indicators could also be listed. Rather than try to use all possible indicators, a laboratory should decide on a manageable number of indicators that would be most critical to patient care. In other words, prioritize the indicators and select those most likely to yield useful information for improving laboratory performance. The indicator chosen for a laboratory s TQI plan should initially cover as broad a range of laboratory activities as possible. After the TQI programme is established, it will then be important to periodically modify the selected indicators. More promising indicators should replace elements of laboratory performance that do not yield useful information. Establish thresholds for selected indicators For each indicator incorporated into the laboratory s TQI programme, an appropriate threshold needs to be established. The threshold sets the critical level of quality laboratory performance for each indicator. Thresholds can be set in either positive or negative format. For example, the threshold for normal fertilization after ICSI could be expressed as: Normal fertilization after ICSI should be at least 60% (positive format); or less than 40% of ICSI oocytes should fail to fertilize normally (2PN two pronuclear) (negative format). Often, the form in which the threshold value is expressed is a function of how the data are being collected. Since clinical protocols are not uniform among IVF laboratories, the threshold values for many indicators may be different from laboratory to laboratory. This point can be illustrated with the following examination of different applications of cryopreservation protocols. Some IVF laboratories have established policies to only freeze high quality embryos. Since it has been shown that embryo quality can impact cryosurvival (Cohen et al., 1986), the threshold level for an indicator of embryo cryosurvival should be relative high in such an IVF programme. Other IVF laboratories have a different approach, and will freeze all nontransferred embryos regardless of quality. Because the overall quality of embryos being frozen is lower, the expectation for survival should also be set at a lower level. On the other hand, other indicators by their nature will have threshold values that will be common to all IVF laboratories. Indicators that measure extremely serious events will be universally set at very low levels. For example, the incidence of insemination with the wrong sperm sample, or the incidence of transferring embryos to the wrong patient will, by their nature, always have a threshold value of zero. Setting the proper threshold value for each indicator is a difficult but extremely critical task for a successful TQI programme. for each of the indicators need to be based on how the specific protocols used in the laboratory impact the outcomes and the nature of indicator s effect on quality of care. As illustrated in Table 2, thresholds that are set too high will erroneously indicate a problem with the laboratory performance. Conversely, a threshold set too low may fail to detect a laboratory deficiency or a poor level of performance. Finally, once a threshold is established, it is important to remember that it is not necessarily an absolute value. When a laboratory fails to meet its expected level of performance for a particular indicator, it is important to determine why the laboratory did not meet this expectation. Investigations may 697
4 Table 1. Examples of indicators of laboratory performance. Aspect of care Indicators Area of laboratory performance Oocyte collection % improper paper work; Communication % retrieval >36 h post-hcg Sperm collection % delayed collection; Communication % rejected semen specimen; % improper paperwork Gamete preparation % motile sperm yield; Technical skill or supply (enzyme) % oocyte degenerate post-stripping Specimen identification % mislabelled semen; Communication % mislabelled oocytes; % insemination mix-up; % thaw error; % transfer mix-up Fertilization % normal fertilization (2PN); Technical skill or equipment % abnormal fertilization; or supply (medium) or lab environment % normal fertilization ICSI; % degenerated post-icsi Cleavage % no cleavage; Equipment or supply (medium) % 4-cell 60 h post-insemination; or lab environment % 8-cell 60 h post-insemination; % blastocyst on day 5; % hatching blastocyst; average embryo grade; average number of cells Cryopreservation % patients with embryo freezing; Technical skill or equipment % survival post-thaw; or supply (medium) or lab environment % cleaved embryos 100% intact; % embryos that cleave post-thaw Embryo transfer % retained embryos in catheter; Technical skill or supply (medium) % transfers good quality embryos or lab environment Laboratory report Average time to final report; Communication Average no. clerical errors; Laboratory safety % lab staff injuries; Staff safety; patient safety % patients with infection postoocyte retrieval or transfer Outcomes % multiple pregnancies; Technical skill or equipment % ectopic; or supply (medium) or lab environment % spontaneous abortion Table 2. Impact of setting the threshold. Result 698 reveal an acceptable reason for a lower threshold value. For instance, an indicator like average embryo grade at transfer could fall below an establish threshold value if the patient population contains a higher than usual number of patients undergoing preimplantation genetic diagnosis (PGD). Since selection of embryos for transfer with a PGD procedure is based on genetic makeup and not necessarily on embryo grade, a drop in the average grade may not be indicating a problem with laboratory performance. It is important to understand that threshold values need to be constantly reviewed and adjusted to the appropriate settings. set too low Threshold value set too high appropriately set Failure to detect lab errors and correct poor performance Standards are impossible to achieve; improvement efforts are misdirected The laboratory has true view of its performance and can effectively direct its effort towards improvements
5 Targeted improvements Unlike QA, which simply seeks out problems/errors and corrects them, a TQI programme seeks to improve laboratory performance in all phases of laboratory activity, not just those indicating poor performance. In the programme at the Jones Institute, areas to be targeted for improvement are periodically identified. These targets are laboratory activities currently functioning at expected levels of performance, but which could significantly impact patient care if improved. This type of activity is philosophically different, since it attempts to proactively improved laboratory performance. QA programmes help laboratories live up to their potentials, while targeted improvements allow TQI to take a laboratory performance to a higher level. By way of illustration, some of the targeted improvements attempted at the Jones Institute over the last few years have included: application of the Spindle View system (LC Polscope, CRI Cambridge, MA, USA) to improve ICSI outcomes; improved embryo culture with the use of a low O 2 (5%) culture system; improved outcomes from freeze/thaw cycles with change in the timing of embryo thawing; and improvement in embryo culture with the use of intra-incubator air filters. Each of these ideas was suggested from the literature or from colleagues. They were incorporated into the laboratory in a controlled fashion for the purpose of improving a specific aspect of laboratory performance. In some cases, improved outcomes were achieved, while in others no improvement was detected. Conclusion The goal of a TQI programme is to improve patient care and satisfaction using a proactive strategy of ongoing evaluation and monitoring. Three key elements of TQI are: (i) understanding the situation; (ii) analysing data; and (iii) improving performance. Considerations and examples of how TQI initiatives may be introduced into an IVF laboratory have been provided. References Cohen J, Simons RS, Fehilly CB, Edwards RG 1986 Factors affecting survival and implantation of cryopreserved human embryos. Journal of In Vitro Fertilization and Embryo Transfer 3, Joint Commission on Accreditation of Health Care Organizations 1991 Transitions From QA to QI. Using CQI approaches to monitor, evaluate and improve quality. Rothmann SA 1995 Developing a quality management program. In: Course X, Laboratory Management. Presented at the 28th Annual Postgraduate Program. American Society for Reproductive Medicine, Seattle, Washington, October 7, pp Wiemer KE, Anderson A, Weikert L 2001 Quality control in the IVF laboratory. In: Gardner DK, Weissman A, Howles CH, Shoham Z (eds) Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives. Martin Dunitz, London, pp Paper based on contribution presented at the TWIN Meeting Alpha Andrology 2003 in Antwerp, Belgium, September Received 13 May 2003; refereed 28 May 2003; accepted 3 June
Mishaps: How and Why Mistakes Occur in the Assisted Reproductive Technologies Laboratory, and How to Prevent Them
Mishaps: How and Why Mistakes Occur in the Assisted Reproductive Technologies Laboratory, and How to Prevent Them Andrew R. La Barbera, Ph.D., H.C.L.D. Professor of Obstetrics and Gynecology Professor
More informationCollege of Physicians and Surgeons of Saskatchewan STANDARDS. Assisted Reproductive Technology PREAMBLE
College of Physicians and Surgeons of Saskatchewan STANDARDS Assisted Reproductive Technology STATUS: UNDER REVIEW Approved by Council: September 2012 Amended: November 2015 To be reviewed: November 2020
More informationQuality Control Processes Within the Embryology Laboratory. Klaus E. Wiemer, PhD Laboratory Director
Quality Control Processes Within the Embryology Laboratory Klaus E. Wiemer, PhD Laboratory Director 8/28/2015 1 Introduction Thorough understanding of every process that occurs within the IVF lab is essential
More informationUnderstanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre
Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their
More informationRAH s Regional Fertility & Women s Endocrine Clinic FAQs
RAH s Regional Fertility & Women s Endocrine Clinic FAQs What changes are being made to the Regional Fertility & Women s Endocrine Clinic at the Lois Hole Hospital for Women in the Royal Alexandra Hospital
More informationCONSENT FOR ASSISTED REPRODUCTION In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Freezing and Disposition
CONSENT F ASSISTED REPRODUCTION In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Freezing and Disposition Please read the following consent carefully. If you do not understand
More informationCRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE
INFERTILITY & IVF MEDICAL ASSOCIATES OF WESTERN NEW YORK CRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE BUFFALOIVF.COM When you have scheduled your appointment with Dr Crickard or Dr Sullivan to sign
More informationAmerican Society for Reproductive Medicine, Birmingham, Alabama
PRACTICE COMMITTEE FERTILITY AND STERILITY VOL. 82, NO. 6, DECEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Revised
More informationAbstract. Introduction. Materials and methods. Patients and methods
RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos
More informationPOST - DOCTORAL FELLOWSHIP PROGRAMME IN REPRODUCTIVE MEDICINE. Anatomy : Male and Female genital tract
POST - DOCTORAL FELLOWSHIP PROGRAMME IN REPRODUCTIVE MEDICINE DURATION OF THE COURSE : TWO YEARS Detailed syllabus: Part 1 Basic Sciences: Anatomy : Male and Female genital tract Physiology Endocrinology
More informationThe Viability Of Human Embryos After Transport In A Dry Shipper Between Assisted Conception Laboratories
Article ID: WMC001104 2046-1690 The Viability Of Human Embryos After Transport In A Dry Shipper Between Assisted Conception Laboratories Corresponding Author: Ms. Clare Pinkus, Scientist, Hollywood Fertility
More informationAnalysis of factors affecting embryo implantation
Analysis of factors affecting embryo implantation Andrew L.Speirst, H.W.G.Baker and Nusratudin Abdullah The Royal Women's Hospital, Melbourne, Australia ITo whom correspondence should be addressed Introduction
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationAbstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 15 December 2003
RBMOnline - Vol 8. No 2. 207-211 Reproductive BioMedicine Online; www.rbmonline.com/article/1023 on web 15 December 2003 Article Determining the most optimal stage for embryo cryopreservation Anthony Anderson
More informationFertility treatment in trends and figures
Fertility treatment in 2010 trends and figures Contents Page No: Foreword by the Chair of the HFEA 3 Summary 4 Section 1: Overview How many fertility clinics were there in the UK in 2010? 6 How many women
More informationINFERTILITY SERVICES
INFERTILITY SERVICES Protocol: OBG036 Effective Date: August 1, 2018 Table of Contents Page COMMERCIAL COVERAGE RATIONALE... 1 DEFINITIONS... 4 MEDICARE AND MEDICAID COVERAGE RATIONALE... 5 REFERENCES...
More informationASSISTED REPRODUCTIVE TECHNOLOGIES (ART)
ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Geneva Foundation for Medical Education and research Definitions
More informationA very warm welcome to the Herts & Essex Fertility Centre
A very warm welcome to the Herts & Essex Fertility Centre Herts & Essex Fertility Centre is one of the UK s most reputable and best-performing IVF clinics. Since 1989, our dedicated team has helped with
More informationFemale Patient Name: Social Security # Male Patient Name: Social Security #
Female Patient Name: Social Security # Male Patient Name: Social Security # THE CENTER FOR HUMAN REPRODUCTION (CHR) ILLINOIS/NEW YORK CITY * ASSISTED REPRODUCTIVE TECHNOLOGIES PROGRAM (A.R.T.) CRYOPRESERVATION
More informationA very warm welcome to the Herts & Essex Fertility Centre
A very warm welcome to the Herts & Essex Fertility Centre Herts & Essex Fertility Centre is one of the UK s most reputable and best-performing IVF clinics. Since 1989, our dedicated team has helped with
More informationPreimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent
Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent PGT analysis is offered to patients that seek to identify a chromosomal abnormality in their embryos prior to initiating
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationFROM GAMETES TO BLASTOCYSTS. Simpler Processes, Less Stress, Better Results.
FROM GAMETES TO BLASTOCYSTS Simpler Processes, Less Stress, Better Results. HELP AT EVERY STEP with simpler processes, less stress and better results Multipurpose Handling Medium RETRIEVE AND RINSE OOCYTES
More informationCambridge IVF. Creating your future. Addenbrooke's Hospital Rosie Hospital
Cambridge IVF Creating your future Addenbrooke's Hospital Rosie Hospital We want to make Cambridge IVF unique in its patient focus Mr Raj Mathur lead clinician Creating your future Cambridge IVF Cambridge
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationTherapeutic Sperm Banking
Therapeutic Sperm Banking An Option for Preserving Male Fertility Andrology Laboratory and Reproductive Tissue Bank Information For Patients Men undergoing cancer treatment, including certain types of
More information(A) In-Vitro Fertilization (per cycle) HKD Payable to (1) Standard Drug Package (IVF) $11,000 CUHK. (5) Laboratory Fee for Embryo Transfer $1,800 CUHK
The services provided by this Unit are funded by both the Chinese University of Hong Kong () and the Hospital Authority (). You will therefore receive bills from both and. Payment to the Chinese University
More informationCONSENT FOR CRYOPRESERVATION OF EMBRYOS
CONSENT FOR CRYOPRESERVATION OF EMBRYOS We, (Female Partner) and (Partner, Spouse), as participants in the in vitro fertilization (IVF) program at the Reproductive fertility center (REPRODUCTIVE FERTILITY
More informationSOUTHEND CENTRES FERTILITY CLINICS. FOR APPOINTMENTS CALL , DELHI
SOUTHEND CENTRES DELHI Holy Angels Hospital, First Floor, Basant Lok, Vasant Vihar Saket City Hospital, Mandir Marg, Press Enclave Road, Saket Southend IVF & Fertility Centre, B 362-364, Outer Ring Road,
More informationFinancial Information for Patients Valid from 1 September Fertility Assessment and Consultations
Financial Information for Patients Valid from 1 September 2017 This fee schedule is designed to give you information regarding the costs involved for fertility treatment at Cambridge IVF. If any aspect
More informationSTEPHEN R. LINCOLN, MD, FACOG Board Certified Reproductive Endocrinologist
Our Physicians STEPHEN R. LINCOLN, MD, FACOG Stephen R. Lincoln is board certified in obstetrics and gynecology and subspecialty board certified in reproductive endocrinology and infertility. Dr. Lincoln
More informationPlanning for Parenthood After a Cancer Diagnosis
Cancer and Fertility Planning for Parenthood After a Cancer Diagnosis If you or someone you love is facing cancer, preserving fertility may be the last thing on your mind. But if you re a woman of childbearing
More informationWe can give you the very best chance of having a baby.
We can give you the very best chance of having a baby www.ivf-iscare.com ISCARE was founded in 1994 as a first private clinic specialized in reproductive medicine in the Czech Republic. This centre of
More informationPossibilities Plan. Access to the care you need.
Possibilities Plan If you do not have insurance or have insurance but lack coverage for infertility services and are concerned about the cost of infertility services, The Center for Advanced Reproductive
More informationFertility Services Commissioning Policy
Fertility Services Commissioning Policy NEE CCG Policy Reference: Where patients have commenced treatment in any cycle prior to this version becoming effective, they are subject to the eligibility criteria
More informationMyths About Success Rates Do they truly reflect quality of care
Myths About Success Rates Do they truly reflect quality of care Barry Behr PhD., HCLD Professor and IVF Laboratory Director Division of Reproductive Endocrinology and Infertility Dept OB/GYN Stanford University
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationWelcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2
Welcome Your fertility treatment journey begins here Fertility treatment can be complicated Managing expectations, keeping track of medications and appointments, remembering all the information your physician
More informationFERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida
FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer
More informationCommissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services
Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Reference No: Version: 2 Ratified by: EMSCGP006V2 EMSCG Date ratified:
More informationNEW YORK STATE MODEL FOR REGULATORY OVERSIGHT OF ART AND GENETIC TESTING.
NEW YORK STATE MODEL FOR REGULATORY OVERSIGHT OF ART AND GENETIC TESTING. Ann M. Willey, Ph.D Adjunct Professor, University at Albany & Albany Law School PROFESSOR WILLEY: First I want to congratulate
More informationUNIVERSITY OF WASHINGTON MEDICAL CENTER Men s Health Center and Male Fertility Laboratory Sperm & Testis Cryopreservation Program Patient NAME and ID
UNIVERSITY OF WASHINGTON MEDICAL CENTER Men s Health Center and Male Fertility Laboratory Sperm & Testis Cryopreservation Program Patient NAME and ID CONSENT FOR MINOR s SPERM OR TESTIS CRYOPRESERVATION
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More information1 - Advanced clinical course for ART with Hands on
1 of 7 1 - Advanced clinical course for ART with Hands on Duration: 30 days Course Fee: Rs 1,00,000 I. Anatomy & Physiology of Male & Female reproduction. II. Evaluation of infertile couple III. Counselling
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationEuropean IVF Monitoring (EIM) Year: 2013
European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility
More informationConsent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition
Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Patient Name (please print) Patient DOB (MM/DD/YYYY) Patient eivf number Partner
More informationBringing Life to the Living
Bringing Life to the Living ReGenesis Where Life Begins Centre for Assisted Reproduction, Endoscopy and Fetal Medicine Traditionally, infertility is defined as the inability to conceive for more than two
More informationM Magdy EL-Sheikh FRCOG London, FRCS Glasgow Director ART unit Dr Soliman Fakeeh hospital Jeddah Saudi Arabia
M Magdy EL-Sheikh FRCOG London, FRCS Glasgow Director ART unit Dr Soliman Fakeeh hospital Jeddah Saudi Arabia The versatile nature reproduction Reproduction as a sign of life Reproduction as a sign of
More informationResearch Licence Renewal Inspection Report
Research Licence Renewal Inspection Report Project Title The vitrification of blastocysts following biopsy at the earlycleavage stage or blastocyst stage of embryo development A Pilot Study Research Licence
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationClinical Policy Committee
Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationIVF & SURROGACY STANDARD OPTION PRICING LIV FERTILITY CENTER, PUERTO VALLARATA, MEXICO AUTUMN 2015
IVF & SURROGACY STANDARD OPTION PRICING LIV FERTILITY CENTER, PUERTO VALLARATA, MEXICO AUTUMN 2015 SURROGACY WITH 3 RD PARTY EGG DONOR Standard Fees & Payment Schedule Agency Fee: $4,500 USD a Consultancy
More informationEast and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2015 1 1. Introduction This policy sets out the entitlement and service that will
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar
More informationWELCOME TO NYU LANGONE FERTILITY CENTER
WELCOME TO NYU LANGONE FERTILITY CENTER Welcome Madison Women s Health & Fertility Patients... 2 Checklist for Getting Started... 2 Important Numbers... 2 Financial Information... 2 Financial Verification...
More informationIn this document, you will find information about donor screening and selection and all forms needed to reserve and purchase your eggs.
Thank you for choosing Tennessee Reproductive Medicine (TRM) as your donor egg source, it is a privilege to help you with one of the most important decisions of your life. TRM offers the purchase of frozen
More informationCONSENT TO CRYOPRESERVATION AND STORAGE OF HUMAN EMBRYOS
1. Name(s) of Party/Parties A. Party/parties requesting freezing of embryos a. Couple We, and of County, City of in the state of are (married or domestic partners) and are over the age of twenty-one years.
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number 2.0 Ratified by HVCCG Exec Team Date Ratified 9 th November 2017 Name of Originator/Author Dr Raj Nagaraj
More informationAssisted Conception Policy
Assisted Conception Policy NHS Eligibility Criteria for assisted conception services (excluding In vitro fertilisation (IVF) Intracytoplasmic sperm injection (ICSI) treatment) for people with infertility
More informationCRAFT HOSPITAL & RESEARCH CENTRE
CRAFT HOSPITAL & RESEARCH CENTRE Centre for Excellence in Infertility Treatment, IUI, IVF, ICSI, Neonatology, Foetal Medicine, Andrology & Sexology, Laparoscopic Surgery and Medical Genetics Kodungallur,
More informationFRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018
FRESH OR FROZEN EMBYOS WHAT IS THE LATEST EVIDENCE? DR. ASMA MOMANI CLEVELAND CLINIC, ANDROLOGY LAB TRAINEE 2018 OBJECTIVES Hisory Indication of freezing embryos Slow freezing versus vitrification Advantages
More informationFertility Services Commissioning Policy
Fertility Services Commissioning Policy NEE CCG Policy Reference: NEE/CCG/2015/057 Where patients have commenced treatment in any cycle prior to this version becoming effective, they are subject to the
More informationConsent to Shipment of Frozen Embryos to and Short Term Storage of Frozen Embryos at the Family Fertility Center
1. Background On or about and requested clinic and treating physician) at (date), name(s) of parties underwent IVF treatment) (name of (address of clinic) to perform in vitro fertilization using: a. Oocyte
More informationClinical Policy Committee
Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year
More informationFertility Preservation for Trans Women: Sperm Banking
Fertility Preservation for Trans Women: Sperm Banking A PUBLICATION OF FAIRFAX CRYOBANK About the Author Michelle Ottey, PhD, HCLD is the Director of Operations for Fairfax Cryobank and Cryogenic Laboratories,
More informationBumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.
a. Date of notification: b. Name of reporting site: c.name of doctor in charge: AI : FEMALE PATIENT DETAILS & DEMOGRAPHICS (Instruction: if Mykad is not available, please complete Old IC or other ID document
More informationIN VITRO FERTILISATION (IVF)
IN VITRO FERTILISATION (IVF) Pre Treatment - first cycle 785 Medical Consultation 225 Nurse Planning 235 Baseline ultrasound scan of uterus and ovaries HIV, Hep B antibodies, Hep B antigen, Hep C blood
More informationNumber of oocytes and live births in IVF
Number of oocytes and live births in IVF Dr Sesh K Sunkara MD, MRCOG Royal Marsden Hospital, London Kings Healthcare Partners (Guy s & St Thomas NHS Foundation Trust), London, UK Background IVF results
More informationWHAT IS A PATIENT CARE ADVOCATE?
WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing
More informationPolicy statement. Commissioning of Fertility treatments
Policy statement Commissioning of Fertility treatments NB: The policy relating to commissioning of fertility treatments is unchanged from the version approved by the CCG in March 2017. The clinical thresholds
More informationSociety for Assisted Reproductive Technology and American Society for Reproductive Medicine
FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ASRM/SART REGISTRY
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number Name of Originator/Author Cross Reference V2 East of England Consortium Commissioning Policy for Fertility
More informationAndrology Services at HA Past, Present and Future. W.S.B. Yeung Department of Obstetrics and Gynaecology The University of Hong Kong
Andrology Services at HA Past, Present and Future W.S.B. Yeung Department of Obstetrics and Gynaecology The University of Hong Kong Content How is semen analysis done? Is it useful? Past Present Future
More informationReproductive Medicine Module 4a: Subfertility and Assisted Conception 4a: General Subfertility
Reproductive Medicine Module 4a: Subfertility and Assisted Conception 4a: General Subfertility = Not required Pathology/Immunology/Anatomy Uterus, tubes, ovaries Adrenal/thyroid Pituitary Testis Investigation
More informationIVF: PAST, PRESENT AND FUTURE
IVF: PAST, PRESENT AND FUTURE Mark Larman Chief Scientific Officer 1 HISTORY OF IVF IVF first achieved with rabbits in 1959 IVF with human gametes - pioneered by Robert Edwards and Patrick Steptoe during
More informationTECHNICAL GUIDANCE FOR THE ACCREDITATION OF ANDROLOGY LABORATORIES
TECHNICAL GUIDANCE FOR THE ACCREDITATION OF ANDROLOGY LABORATORIES Approved By: Chief Executive Officer: Ron Josias Accreditation Executive: Mpho Phaloane Revised By: Medical Specialist Technical Committee
More informationCOMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.
COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.
*40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print
More informationRecommended Interim Policy Statement 150: Assisted Conception Services
Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations
More informationUnderstanding IVF Processes in Surrogacy
Melvin H. Thornton II MD Medical Director CT Fertility Understanding IVF Processes in Surrogacy The Basics Surrogacy involves multiple parties IVF CLINIC Egg donors screening and matching* Medical process
More informationSHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)
SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs) Policy Recommendation 002: Assisted Conception Services Date of Issue: September 2014
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationFertility treatment in trends and figures
Fertility treatment in 2011 trends and figures Contents Page No: Chair s foreword 3 Summary 4 Background 5 Frequently asked questions 7 Section 1: Overview How many fertility clinics were there in the
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Cryopreservation to preserve e fertility in people diagnosed with cancer bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They
More informationAlways placing innovation and excellence at the heart of our strategy, clinique ovo aims to meet your expectations and support your family project.
Always placing innovation and excellence at the heart of our strategy, clinique ovo aims to meet your expectations and support your family project. Since 2003, ovo fertility offers comprehensive assisted
More informationSPECIALIST FERTILITY SERVICES CLINICAL CRITERIA & CONTRACT AWARD
AGENDA ITEM 8 GOVERNING BODY MEETING IN PUBLIC ON 25 TH SEPTEMBER 2014 SPECIALIST FERTILITY SERVICES CLINICAL CRITERIA & CONTRACT AWARD Date of the meeting 25 th September 2014 Author Sponsoring Board
More informationSynchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
More informationFertility & Sterility Copyright 1999 American Society for Reproductive Medicine. Volume 72(4) October 1999 pp
Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine Volume 72(4) October 1999 pp 679-685 Embryo implantation in in vitro fertilization and intracytoplasmic sperm injection:
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationOptimize your success
ANDROLOGY BY ORIGIO Optimize your success by selecting the highest quality sperm QUALITY CONTROL OOCYTE RETRIEVAL ANDROLOGY & IUI FERTILIZATION CULTURE PGD & PGS CRYOPRESERVATION EMBRYO TRANSFER The importance
More informationUnidad de Reproducción Centro Gutenberg
Unidad de Reproducción Centro Gutenberg Working for your dreams www.urecentrogutenberg.es THE UNIT The Gutenberg Centre Reproduction Unit (URE) was established in Malaga in 1987. With a team of more than
More informationJournal of Assisted Reproduction and Genetics Plenum Publishing Corporation All Rights Reserved.
Journal of Assisted Reproduction and Genetics Plenum Publishing Corporation 2003. All Rights Reserved. Volume 20(1) January 2003 p 38 45 Can Westgard Quality Control Rules Determine the Suitability of
More informationEuropean IVF Monitoring (EIM) Year: 2012
European IVF Monitoring (EIM) Year: 2012 Name of the country Poland Name and full address of the contact person. Professor Rafal Kurzawa, MD PhD Wojska Polskiego 103 Street 70-483 Szczecin Poland Telephone
More informationAugust 2017 Changes. Reproductive Laboratory Checklist. CAP Accreditation Program
August 2017 Changes Reproductive Laboratory Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.21.2017 Disclaimer and Copyright
More informationAdvanced Assisted Reproductive Technologies
Advanced Assisted Reproductive Technologies 體外受孕中心 IVF Centre IVF CENTRE at Hong Kong Sanatorium & Hospital The IVF Centre at Hong Kong Sanatorium & Hospital has been offering excellent patient care and
More informationPlacename CCG. Policies for the Commissioning of Healthcare. Policy for Assisted Conception Services
Placename CCG Policies for the Commissioning of Healthcare Policy for Assisted Conception Services 1 Introduction 1.1 This document is part of a suite of policies that the CCG uses to drive its commissioning
More information